If you have been reading about tetrapeptide and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-12-13. Where a claim depends on a specific study, the study is described rather than over-claimed.
Residue composition is the property that most cleanly separates verified material from mislabelled samples. Alanine, glutamate, aspartate and glycine appear in that order from the N-terminus, and the two acidic residues sit in the middle of the chain. Because the peptide is short, it can be produced by solid-phase synthesis and characterised by mass spectrometry without ambiguity. Any reported sample whose measured mass departs substantially from 390 daltons is a different compound or a degraded mixture rather than epitalon.
Epitalon is a synthetic tetrapeptide whose four residues are alanine, glutamate, aspartate and glycine, commonly abbreviated AEDG. Its molecular formula is C14H22N4O9 and its monoisotopic mass is near 390.35 daltons. The peptide carries two acidic side chains, so it is neutral to negatively charged in most aqueous buffers. Published reference summaries usually list it under both spellings, epitalon and epithalon, and treat the two names as the same material.
Published work on this compound consists mainly of in vitro experiments, animal studies, and small clinical investigations, a substantial share of which appeared in Russian-language journals. Sample sizes are generally small, control conditions differ between studies, and several endpoints rely on markers whose clinical meaning is itself debated. Reviews of the longevity field treat the peptide as an early example of telomerase-directed research rather than an established intervention. Regulatory treatment varies by country: some jurisdictions place it under prescription controls, others treat it as a laboratory material, and importation may be restricted regardless of local status.
Epitalon is a synthetic tetrapeptide whose sequence is alanine–glutamate–aspartate–glycine, commonly abbreviated AEDG. It was developed in Russia during the 1980s and 1990s by investigators associated with the St. Petersburg Institute of Bioregulation and Gerontology, who studied short peptides as regulators of gene expression and tissue function. The alternative spelling epithalon appears interchangeably in the literature, and the two names refer to the same molecule. Outside Russia it is encountered chiefly as a research chemical rather than a licensed medicine, and it holds no approval from the United States Food and Drug Administration or the European Medicines Agency.
The peptide is a synthetic analogue of epithalamin, a preparation extracted from bovine pineal glands. Investigators sought a short, chemically defined molecule that would reproduce some of the endocrine and gerontological observations attributed to the glandular extract. Proposed mechanisms centre on induction of telomerase activity, an effect reported in cultured human somatic cells in the early 2000s, together with influences on melatonin secretion and neuroendocrine regulation. Those mechanisms remain incompletely characterised, and the reported telomerase response has not been consistently reproduced by independent groups working in comparable systems.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C14H22N4O9 | Derived from the four constituent residues |
| Molecular mass | About 390.35 Da | Monoisotopic value, confirmed by mass spectrometry |
| Residue sequence | Ala-Glu-Asp-Gly | Read from the N-terminus to the C-terminus |
| Common synonyms | Epithalon; AEDG | Both forms appear in reference catalogues |
| Net charge near neutral pH | Negative | Two acidic side chains give a low isoelectric point |
Several names circulate for the same molecule, including epitalon, epithalone, epithalamin tetrapeptide, and the sequence code AEDG. A CAS registry number, 307297-39-8, is commonly cited for it, though catalogue entries should be checked against supplier documentation because mislabelled records occur. In its usual form the peptide carries free amino and carboxyl termini and is neither glycosylated nor lipidated. Researchers distinguish the defined tetrapeptide from epithalamin itself, a crude pineal preparation containing many peptides that is not chemically characterised.
Material supplied for laboratory use is normally a lyophilised white to off-white powder that dissolves readily in water and in isotonic saline. Lyophilised cakes are hygroscopic and should be equilibrated to room temperature before opening to limit condensation on the solid. Solutions are typically prepared at milligram-per-millilitre concentrations and divided into single-use aliquots, because repeated freeze–thaw cycles degrade short peptides. Aqueous solutions are far less stable than the dry powder, and identity is usually verified by mass spectrometry alongside purity estimation from reversed-phase high-performance liquid chromatography.
Epitalon is a synthetic linear tetrapeptide with the sequence alanine–glutamate–aspartate–glycine, abbreviated AEDG. Its molecular formula is C14H22N4O9 and the calculated mass is approximately 390.35 g/mol. The compound is made by solid-phase peptide synthesis rather than extracted from tissue, although early work described it as a short fragment of a peptide fraction obtained from bovine pineal extract. In the research literature the spelling epitalon and the variant epithalone both appear, while AEDG is the standard code used in peptide nomenclature.
Epitalon is a synthetic tetrapeptide whose sequence is alanine-glutamate-aspartate-glycine, written in single-letter code as AEDG. The four residues are joined by three peptide bonds, giving a linear backbone with no branching and no disulfide bridges. Its calculated molecular mass for the free form is approximately 390.3 daltons, a figure that rises when the compound is supplied as an acetate or trifluoroacetate salt. Because the chain is short, the molecule is defined entirely by its residue order rather than by any folded three-dimensional structure.
The compound is described in the literature as a derivative of epithalamin, a preparation obtained from bovine pineal tissue. Work on this peptide family was carried out mainly by a research group in Saint Petersburg beginning in the 1980s, and the substance was later registered for clinical use in Russia under the name Epitalon. Outside that region it is generally treated as a research chemical rather than an approved medicine. Statements about its biological activity rest on a relatively small number of studies, and independent replication remains limited.
=== Preclinical === AM-510 – undefined mechanism of action – opioid-related disorders ATI-1013 – monoclonal antibody against nicotine – smoking withdrawal CTRX-1001 – immunostimulant – opioid-related disorders CTRX-2001 – immunostimulant – opioid-related disorders Cyclobenzaprine (KRL-102; TNX-102; Tonmya; VLD-cyclobenzaprine) – tricyclic antidepressant (various actions) – alcoholism Cyproheptadine/prazosin (KT-110; Periactine/Alpress) – combination of cyproheptadine (various actions) and prazosin (α1-adrenergic receptor antagonist) – cocaine-related disorders Dimethyltryptamine (DMT; EBRX-101) – non-selective serotonin receptor agonist, serotonin 5-HT2A receptor agonist, and serotonergic psychedelic – alcoholism EQL-101 – undefined mechanism of action (non-hallucinogenic non-cardiotoxic ibogaine derivative) – substance use disorders Flumazenil/naloxone transdermal patch (MX-1607; RescuePatch) – combination of flumazenil (GABAA receptor negative allosteric modulator/benzodiazepine antagonist) and naloxone (opioid receptor antagonist) – substance-related disorders GM-3009 – κ-opioid receptor agonist (noribogaine analogue) – opioid-related disorders INDV-1000 (GABAB PAM) – GABAB receptor positive allosteric modulator – substance-related disorders KB-128 – serotonin 5-HT2C receptor G protein-biased agonist, serotonin 5-HT2A and 5-HT2B receptor antagonist – alcoholism LPH-48 – undefined mechanism of action and serotonergic psychedelic ((shorter-acting LPH-5 analogue) – alcoholism M-101 – GABA receptor antagonist – substance-related disorders 5-Methoxy-2-aminoindane (MEAI; 5-MeO-AI; CMND-100) – serotonin–norepinephrine releasing agent – cocaine-related disorders Metyrapone/oxazepam (EMB-001C; EMB-001) – combination of metyrapone (11β-hydroxylase inhibitor and cortisol synthesis inhibitor) and oxazepam (benzodiazepine/GABAA receptor positive allosteric modulator) – substance-related disorders Midomafetamine microneedle transdermal patch (MDMA; ecstasy) – serotonin, norepinephrine, and dopamine releasing agent, weak serotonin 5-HT2 receptor agonist, entactogen – substance-related disorders Naltrexone controlled-release (BICX101, BICX-101) – opioid receptor antagonist – alcoholism, opioid-related disorders Nicotine degrading enzyme (ATI-3009; NicA2; NicA2-J1) – enzyme – smoking withdrawal PPL-138 (BU10038, BU-10038) – nociceptin receptor agonist, μ-opioid receptor agonist, opioid peptide agonist – alcoholism, cocaine-related disorders PSIL-001 (DMT analogue) – non-hallucinogenic serotonin 5-HT1 receptor modulator – substance-related disorders PSIL-002 (DMT analogue) – non-hallucinogenic serotonin 5-HT1 receptor modulator – substance-related disorders Psilacetin (O-acetylpsilocin; 4-AcO-DMT) – non-selective serotonin receptor agonist, serotonin 5-HT2A receptor agonist, serotonergic psychedelic – substance-related disorders Pudafensine (IP-2015; IP-2017; IPNP-2015; IPTN-2021) – serotonin–norepinephrine–dopamine reuptake inhibitor – substance-related disorders Research programme: psychedelic-based neurological therapeutics - Psilera – undefined mechanism of action and serotonergic psychedelics – alcoholism Research programme: psychoplastogen therapeutics - Collaborations Pharmaceuticals – undefined mechanism of action – opioid-related disorders SVN-015 – serotonin–dopamine reuptake inhibitor – substance-related disorders SXC-2023 – cystine–glutamate antiporter (SLC7A11; System xc- or Sxc) activator – cocaine-related disorders, smoking withdrawal [15] [16] TACT411 – serotonin 5-HT1B receptor modulator and monoamine transporter modulator – alcoholism TACT523 – undefined mechanism of action – alcoholism TACT833 – serotonin 5-HT1B receptor modulator and monoamine transporter modulator – alcoholism VS-01 (VS-01-HAC) – ammonia scavenger – substance-related disorders
=== Healthcare === Kiggans voted against extending Affordable Care Act subsidies in December 2025. Kiggans supports banning abortions after fifteen weeks of pregnancy, except for in cases of rape, incest, or to protect the life of the mother. In June 2022, she expressed support for the U.S. Supreme Court's ruling in Dobbs v. Jackson Women's Health Organization, which overruled Roe v. Wade.
After Charles's death, the former Austrian imperial family were soon to move again. Alfonso XIII of Spain had approached the British Foreign Office via his ambassador in London, and they agreed to allow Zita and her seven (soon to be eight) children to relocate to Spain. Alfonso duly sent the warship Infanta Isabel to Funchal and this took them to Cádiz. They were then escorted to the Pardo Palace in Madrid, where shortly after her arrival Zita gave birth to Archduchess Elisabeth. Alfonso XIII offered his exiled Habsburg relatives the use of Palacio Uribarren at Lekeitio on the Bay of Biscay. This appealed to Zita, who did not want to be a heavy burden to the state that harboured her. For the next six years Zita settled in Lekeitio, where she got on with the job of raising and educating her children. They lived with straitened finances, mainly living on income from private property in Austria, income from a vineyard in Johannisberg in the Rhine Valley, and voluntary collections. Other members of the exiled Habsburg dynasty, however, claimed much of this money, and there were regular petitions for help from former Imperial officials.
== Clinical targets in various disorders == Preventing the release of DAMPs and blocking DAMP receptors would, in theory, stop inflammation from an injury or infection and reduce pain for the affected individual. This is especially important during surgeries, which have the potential to trigger these inflammation pathways, making the surgery more difficult and dangerous to complete. The blocking of DAMPs also has theoretical applications in therapeutics to treat disorders such as arthritis, cancer, ischemia reperfusion, myocardial infarction, and stroke. These theoretical therapeutic options include:
=== Pharmacokinetics === The extent of absorption of cocaine into the circulatory system after nasal insufflation is similar to that after oral ingestion. The rate of absorption after nasal insufflation is limited by cocaine-induced vasoconstriction of capillaries in the nasal mucosa. Onset of absorption after oral ingestion is delayed because cocaine is a weak base with a pKa of 8.6, and is thus in an ionized form that is poorly absorbed from the gastric acid and easily absorbed from the alkaline duodenum. The rate and extent of absorption from inhalation of cocaine is similar or greater than with intravenous injection, as inhalation provides access directly to the capillary bed. The delay in absorption after oral ingestion may account for the popular belief that cocaine bioavailability from the stomach is lower than after insufflation. Compared with ingestion, the faster absorption of insufflated cocaine results in quicker attainment of maximum drug effects. Snorting cocaine produces maximum physiological effects within 40 minutes and maximum psychotropic effects within 20 minutes. Physiological and psychotropic effects from nasally insufflated cocaine are sustained for approximately 40–60 minutes after the peak effects are attained. Cocaine crosses the blood–brain barrier via both a proton-coupled organic cation antiporter and (to a lesser extent) via passive diffusion across cell membranes. As of September 2022, the gene or genes encoding the human proton-organic cation antiporter had not been identified.
Sources: en.wikipedia.org
Interferons were first described in 1957 by Alick Isaacs and Jean Lindenmann at the National Institute for Medical Research in London; the discovery was a result of their studies of viral interference. Viral interference refers to the inhibition of virus growth caused by previous exposure of cells to an active or a heat-inactivated virus. Isaacs and Lindenmann were working with a system that involved the inhibition of the growth of live influenza virus in chicken embryo chorioallantoic membranes by heat-inactivated influenza virus. Their experiments revealed that this interference was mediated by a protein released by cells in the heat-inactivated influenza virus-treated membranes. They published their results in 1957 naming the antiviral factor they had discovered interferon. The findings of Isaacs and Lindenmann have been widely confirmed and corroborated in the literature. Furthermore, others may have made observations on interferons before the 1957 publication of Isaacs and Lindenmann. For example, during research to produce a more efficient vaccine for smallpox, Yasu-ichi Nagano and Yasuhiko Kojima—two Japanese virologists working at the Institute for Infectious Diseases at the University of Tokyo—noticed inhibition of viral growth in an area of rabbit-skin or testis previously inoculated with UV-inactivated virus. They hypothesised that some "viral inhibitory factor" was present in the tissues infected with virus and attempted to isolate and characterize this factor from tissue homogenates.
==== Adolescents ==== Health Canada has not developed advice for adolescents because of insufficient data. However, they suggest that daily caffeine intake for this age group be no more than 2.5 mg/kg body weight. This is because the maximum adult caffeine dose may not be appropriate for light-weight adolescents or for younger adolescents who are still growing. The daily dose of 2.5 mg/kg body weight would not cause adverse health effects in the majority of adolescent caffeine consumers. This is a conservative suggestion since older and heavier-weight adolescents may be able to consume adult doses of caffeine without experiencing adverse effects.
=== C1q chains A, B and C === C1q is composed of 18 polypeptide chains: six A-chains, six B-chains, and six C-chains. Each chain contains a collagen-like region located near the N terminus and a C-terminal globular region. The A-, B-, and C-chains are arranged in the order A-C-B on chromosome 1.
Afonsoconus Tucker & Tenorio, 2013: synonym of Conus (Afonsoconus) Tucker & Tenorio, 2013 represented as Conus Linnaeus, 1758 Africonus Petuch, 1975: synonym of Conus (Lautoconus) Monterosato, 1923 represented as Conus Linnaeus, 1758 Arubaconus Petuch, 2013: synonym of Conus (Ductoconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Asprella Schaufuss, 1869: synonym of Conus (Asprella) Schaufuss, 1869 represented as Conus Linnaeus, 1758 Atlanticonus Petuch & Sargent, 2012: synonym of Conus (Atlanticonus) Petuch & Sargent, 2012 represented as Conus Linnaeus, 1758 Attenuiconus Petuch, 2013: synonym of Conus (Attenuiconus) Petuch, 2013 represented as Conus Linnaeus, 1758 Austroconus Tucker & Tenorio, 2009 synonym of Conus (Austroconus) Tucker & Tenorio, 2009 represented as Conus Linnaeus, 1758 Bathyconus Tucker & Tenorio, 2009: synonym of Conasprella (Fusiconus) Thiele, 1929, represented as Conasprella Thiele, 1929 Bermudaconus Petuch, 2013: synonym of Conus (Bermudaconus) Petuch, 2013 represented as Conus Linnaeus, 1758 Boucheticonus Tucker & Tenorio, 2013: synonym of Conasprella (Boucheticonus) Tucker & Tenorio, 2013 represented as Conasprella Thiele, 1929 Brasiliconus Petuch, 2013: synonym of Conus (Brasiliconus) Petuch, 2013 represented as Conus Linnaeus, 1758 Calamiconus Tucker & Tenorio, 2009: synonym of Conus (Lividoconus) Wils, 1970 represented as Conus Linnaeus, 1758 Calibanus da Motta, 1991: synonym of Conus (Calibanus) da Motta, 1991 represented as Conus Linnaeus, 1758 Cariboconus Petuch, 2003: synonym of Conus (Dauciconus) Cotton, 1945 represented as Conus Linnaeus, 1758 Californiconus Tucker & Tenorio, 2009 Chelyconus Mörch, 1852: synonym of Conus (Chelyconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Cleobula Iredale, 1930: synonym of Dendroconus Swainson, 1840 Coltroconus Petuch, 2013: synonym of Conasprella (Coltroconus) Petuch, 2013 represented as Conasprella Thiele, 1929 Conasprella Thiele, 1929: accepted name Conasprelloides Tucker & Tenorio, 2009: synonym of Conus (Dauciconus) Cotton, 1945 represented as Conus Linnaeus, 1758 † Conilithes Swainson, 1840 Continuconus Tucker & Tenorio, 2013 Conus Linnaeus, 1758: accepted name Cornutoconus Suzuki, 1972: synonym of Taranteconus Azuma, 1972 Coronaxis Swainson, 1840: synonym of Conus (Conus) Linnaeus, 1758 represented as Conus Linnaeus, 1758 Cucullus Röding, 1798: synonym of Conus (Conus) Linnaeus, 1758 represented as Conus Linnaeus, 1758 Cylinder Montfort, 1810: synonym of Conus (Cylinder) Montfort, 1810 represented as Conus Linnaeus, 1758 Cylindrella Swainson, 1840: synonym of Asprella Schaufuss, 1869synonym of Conus (Asprella) Schaufuss, 1869 represented as Conus Linnaeus, 1758 Cylindrus Batsch, 1789: synonym of Cylinder Montfort, 1810synonym of Conus (Cylinder) Montfort, 1810 represented as Conus Linnaeus, 1758 Dalliconus Tucker & Tenorio, 2009: synonym of Conasprella (Dalliconus) Tucker & Tenorio, 2009 synonym of Conasprella Thiele, 1929 Darioconus Iredale, 1930: synonym of Conus (Darioconus) Iredale, 1930 represented as Conus Linnaeus, 1758 Dauciconus Cotton, 1945: synonym of Conus (Dauciconus) Cotton, 1945 represented as Conus Linnaeus, 1758 Dendroconus Swainson, 1840: synonym of Conus (Dendroconus) Swainson, 1840 represented as Conus Linnaeus, 1758 Ductoconus da Motta, 1991: synonym of Conus (Ductoconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Duodenticonus Tucker & Tenorio, 2013: synonym of Conasprella (Conasprella) Thiele, 1929 represented as Conasprella Thiele, 1929 Dyraspis Iredale, 1949: synonym of Conus (Virroconus) Iredale, 1930 represented as Conus Linnaeus, 1758 Elisaconus Tucker & Tenorio, 2013: synonym of Conus (Elisaconus) Tucker & Tenorio, 2013 represented as Conus Linnaeus, 1758 Embrikena Iredale, 1937: synonym of Conus (Embrikena) Iredale, 1937 represented as Conus Linnaeus, 1758 Endemoconus Iredale, 1931: synonym of Conasprella (Endemoconus) Iredale, 1931 represented as Conasprella Thiele, 1929 Eremiconus Tucker & Tenorio, 2009: synonym of Conus (Eremiconus) Tucker & Tenorio, 2009 represented as Conus Linnaeus, 1758 Erythroconus da Motta, 1991: synonym of Conus (Darioconus) Iredale, 1930 represented as Conus Linnaeus, 1758 Eugeniconus da Motta, 1991: synonym of Conus (Eugeniconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Floraconus Iredale, 1930: synonym of Conus (Floraconus) Iredale, 1930 represented as Conus Linnaeus, 1758 Fraterconus Tucker & Tenorio, 2013: synonym of Conus (Fraterconus) Tucker & Tenorio, 2013 represented as Conus Linnaeus, 1758 Fulgiconus da Motta, 1991: synonym of Conus (Phasmoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Fumiconus da Motta, 1991: synonym of Conasprella (Fusiconus) da Motta, 1991 represented as Conasprella Thiele, 1929 Fusiconus da Motta, 1991: synonym of Conasprella (Fusiconus) da Motta, 1991 represented as Conasprella Thiele, 1929 Gastridium Modeer, 1793: synonym of Conus (Gastridium) Modeer, 1793 represented as Conus Linnaeus, 1758 Genuanoconus Tucker & Tenorio, 2009: synonym of Conus (Kalloconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Gladioconus Tucker & Tenorio, 2009: synonym of Conus (Monteiroconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Globiconus Tucker & Tenorio, 2009: synonym of Conasprella (Ximeniconus) Emerson & Old, 1962 represented as Conasprella Thiele, 1929 Gradiconus da Motta, 1991: synonym of Conus (Dauciconus) Cotton, 1945 represented as Conus Linnaeus, 1758 Graphiconus da Motta, 1991: synonym of Conus (Phasmoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Harmoniconus da Motta, 1991: synonym of Conus (Harmoniconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Hermes Montfort, 1810: synonym of Conus (Hermes) Montfort, 1810 represented as Conus Linnaeus, 1758 Heroconus da Motta, 1991: synonym of Conus (Pionoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Isoconus Tucker & Tenorio, 2013: synonym of Conus (Splinoconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Jaspidiconus Petuch, 2004: synonym of Conasprella (Ximeniconus) Emerson & Old, 1962 represented as Conasprella Thiele, 1929 Kalloconus da Motta, 1991: synonym of Conus (Kalloconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Kellyconus Petuch, 2013: synonym of Conus (Kellyconus) Petuch, 2013 represented as Conus Linnaeus, 1758 Kenyonia Brazier, 1896: genus incertae sedis Kermasprella Powell, 1958: synonym of Conasprella (Endemoconus) Iredale, 1931 represented as Conasprella Thiele, 1929 Ketyconus da Motta, 1991: synonym of Conus (Floraconus) Iredale, 1930 represented as Conus Linnaeus, 1758 Kioconus da Motta, 1991: synonym of Conus (Splinoconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Klemaeconus Tucker & Tenorio, 2013: synonym of Conus (Klemaeconus) Tucker & Tenorio, 2013 represented as Conus Linnaeus, 1758 Kohniconus Tucker & Tenorio, 2009: synonym of Conasprella (Kohniconus) Tucker & Tenorio, 2009 represented as Conasprella Thiele, 1929 Kurodaconus Shikama & Habe, 1968: synonym of Conus (Turriconus) Shikama & Habe, 1968 represented as Conus Linnaeus, 1758 Lamniconus da Motta, 1991: synonym of Conus (Lamniconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Lautoconus Monterosato, 1923: synonym of Conus (Lautoconus) Monterosato, 1923 represented as Conus Linnaeus, 1758 Leporiconus Iredale, 1930: synonym of Conus (Leporiconus) Iredale, 1930 represented as Conus Linnaeus, 1758 Leptoconus Swainson, 1840: synonym of Conus (Leptoconus) Swainson, 1840 represented as Conus Linnaeus, 1758 Lilliconus Raybaudi Massilia, 1994: synonym of Conasprella (Lilliconus) G. Raybaudi Massilia, 1994 represented as Conasprella Thiele, 1929 Lindaconus Petuch, 2002: synonym of Conus (Lindaconus) Petuch, 2002 represented as Conus Linnaeus, 1758 Lithoconus Mörch, 1852: synonym of Conus (Lithoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Lividoconus Wils, 1970: synonym of Conus (Lividoconus) Wils, 1970 represented as Conus Linnaeus, 1758 Lizaconus da Motta, 1991synonym of Profundiconus Kuroda, 1956 Magelliconus da Motta, 1991: synonym of Conus (Dauciconus) Cotton, 1945 represented as Conus Linnaeus, 1758 Malagasyconus Monnier & Tenorio, 2015 Mamiconus Cotton & Godfrey, 1932: synonym of Endemoconus Iredale, 1931synonym of Conasprella (Endemoconus) Iredale, 1931 represented as Conasprella Thiele, 1929 Miliariconus Tucker & Tenorio, 2009: synonym of Conus (Virroconus) Iredale, 1930 represented as Conus Linnaeus, 1758 Mitraconus Tucker & Tenorio, 2013: synonym of Conus (Turriconus) Shikama & Habe, 1968 represented as Conus Linnaeus, 1758 Monteiroconus da Motta, 1991: synonym of Conus (Monteiroconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Nataliconus Tucker & Tenorio, 2009: synonym of Conus (Leptoconus) Swainson, 1840 represented as Conus Linnaeus, 1758 Nimboconus Tucker & Tenorio, 2013: synonym of Conus (Phasmoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Nitidoconus Tucker & Tenorio, 2013: synonym of Conus (Splinoconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Ongoconus da Motta, 1991: synonym of Conus (Splinoconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Papyriconus Tucker & Tenorio, 2013: synonym of Conus (Papyriconus) Tucker & Tenorio, 2013 represented as Conus Linnaeus, 1758 Parviconus Cotton & Godfrey, 1932: synonym of Conasprella (Parviconus) Cotton & Godfrey, 1932 represented as Conasprella Thiele, 1929 Perplexiconus Tucker & Tenorio, 2009: synonym of Conasprella (Ximeniconus) Emerson & Old, 1962 represented as Conasprella Thiele, 1929 Phasmoconus Mörch, 1852: synonym of Conus (Phasmoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Pionoconus Mörch, 1852: synonym of Conus (Pionoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Plicaustraconus Moolenbeek, 2008: synonym of Conus (Plicaustraconus) Moolenbeek, 2008 represented as Conus Linnaeus, 1758 Poremskiconus Petuch, 2013: synonym of Conus (Dauciconus) Cotton, 1945 represented as Conus Linnaeus, 1758 Profundiconus Kuroda, 1956: accepted name Protoconus da Motta, 1991: synonym of Tenorioconus Petuch & Drolshagen, 2011 Protostrioconus Tucker & Tenorio, 2009: synonym of Conus (Gastridium) Modeer, 1793 represented as Conus Linnaeus, 1758 Pseudoconorbis Tucker & Tenorio, 2009: synonym of Conasprella (Pseudoconorbis) Tucker & Tenorio, 2009, represented as Conasprella Thiele, 1929 Pseudohermes Tucker & Tenorio, 2013: synonym of Conus (Virgiconus) Cotton, 1945 represented as Conus Linnaeus, 1758 Pseudolilliconus Tucker & Tenorio, 2009: synonym of Conus (Pseudolilliconus) Tucker & Tenorio, 2009 represented as Conus Linnaeus, 1758 Pseudonoduloconus Tucker & Tenorio, 2009: synonym of Conus (Pseudonoduloconus) Tucker & Tenorio, 2009 represented as Conus Linnaeus, 1758 Pseudopterygia Tucker & Tenorio, 2013: synonym of Conus (Pseudopterygia) Tucker & Tenorio, 2013 represented as Conus Linnaeus, 1758 Puncticulis Swainson, 1840: synonym of Conus (Puncticulis) Swainson, 1840 represented as Conus Linnaeus, 1758 Purpuriconus da Motta, 1991: synonym of Conus (Dauciconus) Cotton, 1945 represented as Conus Linnaeus, 1758 Pygmaeconus Puillandre & Tenorio, 2017 Pyruconus Olsson, 1967: synonym of Conus (Pyruconus) Olsson, 1967 represented as Conus Linnaeus, 1758 Quasiconus Tucker & Tenorio, 2009: synonym of Conus (Quasiconus) Tucker & Tenorio, 2009 represented as Conus Linnaeus, 1758 Regiconus Iredale, 1930: synonym of Conus (Darioconus) Iredale, 1930 represented as Conus Linnaeus, 1758 Rhizoconus Mörch, 1852: synonym of Conus (Rhizoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Rhombiconus Tucker & Tenorio, 2009: synonym of Conus (Stephanoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Rhombus Montfort, 1810: synonym of Rhombiconus Tucker & Tenorio, 2009, synonym of Conus (Stephanoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Rolaniconus Tucker & Tenorio, 2009: synonym of Conus (Strategoconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Rollus Montfort, 1810 :synonym of Conus (Gastridium) Modeer, 1793 represented as Conus Linnaeus, 1758 Rubroconus Tucker & Tenorio, 2013: synonym of Conus (Rubroconus) Tucker & Tenorio, 2013 represented as Conus Linnaeus, 1758 Sandericonus Petuch, 2013: synonym of Conus (Sandericonus) Petuch, 2013 represented as Conus Linnaeus, 1758 Sciteconus da Motta, 1991: synonym of Conus (Sciteconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Seminoleconus Petuch, 2003: synonym of Conus (Stephanoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Socioconus da Motta, 1991: synonym of Conus (Pionoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Splinoconus da Motta, 1991: synonym of Conus (Splinoconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Spuriconus Petuch, 2003: synonym of Conus (Lindaconus) Petuch, 2002 represented as Conus Linnaeus, 1758 Stellaconus Tucker & Tenorio, 2009: synonym of Conus (Splinoconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Stephanoconus Mörch, 1852: synonym of Conus (Stephanoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Strategoconus da Motta, 1991: synonym of Conus (Strategoconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Strioconus Thiele, 1929: synonym of Pionoconus Mörch, 1852, synonym of Conus (Pionoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Sulciconus Bielz, 1869: synonym of Asprella Schaufuss, 1869, synonym of Conus (Asprella) Schaufuss, 1869 represented as Conus Linnaeus, 1758 Taranteconus Azuma, 1972: synonym of Conus (Stephanoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Tenorioconus Petuch & Drolshagen, 2011: synonym of Conus (Stephanoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Tesselliconus da Motta, 1991: synonym of Conus (Tesselliconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Textilia Swainson, 1840: synonym of Conus (Textilia) Swainson, 1840 represented Conus Linnaeus, 1758 Thalassiconus Tucker & Tenorio, 2013: synonym of Calibanus da Motta, 1991, synonym of Conus (Calibanus) da Motta, 1991 represented as Conus Linnaeus, 1758 Theliconus Swainson, 1840: synonym of Hermes Montfort, 1810, synonym of Conus (Hermes) Montfort, 1810 represented as Conus Linnaeus, 1758 Thoraconus da Motta, 1991: synonym of Fulgiconus da Motta, 1991, synonym of Conus (Phasmoconus) Mörch, 1852 represented as Conus Linnaeus, 1758 Trovaoconus Tucker & Tenorio, 2009, synonym of Conus (Kalloconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Tuckericonus Petuch, 2013: synonym of Conus (Dauciconus) Cotton, 1945 represented as Conus Linnaeus, 1758 Tuliparia Swainson, 1840: synonym of Gastridium Modeer, 1793, synonym of Conus (Gastridium) Modeer, 1793 represented as Conus Linnaeus, 1758 Turriconus Shikama & Habe, 1968, synonym of Conus (Turriconus) Shikama & Habe, 1968 represented as Conus Linnaeus, 1758 Utriculus Schumacher, 1817: synonym of Gastridium Modeer, 1793, synonym of Conus (Gastridium) Modeer, 1793 represented as Conus Linnaeus, 1758 Varioconus da Motta, 1991: synonym of Conus (Lautoconus) Monterosato, 1923 represented as Conus Linnaeus, 1758 Viminiconus Tucker & Tenorio, 2009: synonym of Conasprella (Fusiconus) da Motta, 1991 represented as Conasprella Thiele, 1929 Virgiconus Cotton, 1945: synonym of Conus (Virgiconus) Cotton, 1945 represented as Conus Linnaeus, 1758 Virroconus Iredale, 1930: synonym of Conus (Virroconus) Iredale, 1930 represented as Conus Linnaeus, 1758 Vituliconus da Motta, 1991: synonym of Conus (Strategoconus) da Motta, 1991 represented as Conus Linnaeus, 1758 Ximeniconus Emerson & Old, 1962: synonym of Conasprella (Ximeniconus) Emerson & Old, 1962 represented as Conasprella Thiele, 1929 Yeddoconus Tucker & Tenorio, 2009: synonym of Conasprella (Endemoconus) Iredale, 1931 represented as Conasprella Thiele, 1929
Sources: en.wikipedia.org
== History == Glenmark was incorporated on 18 November 1977. It began producing generic drugs and active pharmaceutical ingredients for markets in India, Russia, and Africa, and went public on Indian stock exchanges in 1999. Glenn Saldanha, Gracias's son, became managing director in 2001 after working at Eli Lilly and Company and PricewaterhouseCoopers. Under his leadership the company expanded internationally; by 2008 it had become one of India's larger pharmaceutical manufacturers by sales volume, and in 2011 consolidated worldwide sales reached $778 million. That year Glenmark established its first North American manufacturing facility in Monroe, North Carolina. In the mid-2010s, Glenmark changed direction. The generic drug industry was seeing fewer patent expirations, and the company began developing proprietary medicines in oncology, dermatology, and respiratory treatments. It researched drugs internally and licensed them to larger pharmaceutical companies. By 2016, four Glenmark drugs were in clinical development. A respiratory treatment was licensed for commercialisation in North America and Japan, and a diabetes drug was licensed to Merck's German division. Sales that fiscal year were approximately ₹81 billion (about $1.25 billion), ranking it fourth among India's pharmaceutical manufacturers by revenue. Glenmark built a consumer healthcare business in India that included the antifungal Candid, launched in 1979, the respiratory medication Ascoril, and La Shield. It divested the intimate hygiene brand VWash to Hindustan Unilever in March 2020.
At least three isoforms of synuclein are produced through alternative splicing. The majority form of the protein, and the one most investigated, is the full-length protein of 140 amino acids. Other isoforms are alpha-synuclein-126, which lacks residues 41-54 due to loss of exon 3; and alpha-synuclein-112, which lacks residues 103-130 due to loss of exon 5.
6 September – The Daily Record reports that Police Scotland are to begin sending out a "custody user experience survey" via text message to anyone who spends a night in a police cell in Scotland. Scottish climber Lorraine McCall becomes the first woman to climb all 231 Grahams in Scotland during a single journey. 7 September – Police searching for Jenny Hastings, missing since 3 September, find a body at Hound Point in South Queensferry. Several thousand anti-racism protestors, and a smaller number of anti-immigration protestors, march through Glasgow, which is the scene of violent clashes between the two groups. 9 September – It is reported that a woman received a six-figure out-of-court settlement from Lanarkshire Council in 2023 after her adoption of a two-year-old child broke down when she was not made aware the boy had an underlying medical condition. Data from the Scottish Prison Service shows that 188 prisoners, more than a third of the 477 released early over the summer as an emergency measure to free up prison spaces, were convicted of non-sexual violent crimes. 10 September – The body of a female fox is discovered near Balfour Hospital in Kirkwall, Orkney, even though Orkney has no known fox population. 11 September – Figures released by the Scottish Prison Service indicate that the prison population is now higher than when its emergency release scheme began, with 8,241 people in prison in Scotland compared to 8,232 before the scheme began.
Sources: en.wikipedia.org
It is a four-amino-acid peptide built from alanine, glutamate, aspartate and glycine in that order. Its formula is C14H22N4O9, and it is made by chemical synthesis rather than extracted from tissue. The synthetic peptide is a single defined molecule, unlike the pineal extracts it is often compared with.
No. The two spellings refer to the same tetrapeptide, and the difference reflects transliteration from Russian. Laboratories and catalogues use both forms interchangeably. The material is also indexed as AEDG, taken from the one-letter codes of its residues.
Epithalamin is a mixed preparation derived from animal pineal tissue and contains many peptides. Epitalon is one synthetic sequence chosen for study from that broader mixture. Statements about one do not transfer directly to the other.
Epitalon is a synthetic four-amino-acid peptide with the sequence alanine–glutamate–aspartate–glycine, also written AEDG. It was developed in Russian gerontology research and is studied for proposed effects on telomerase, melatonin regulation, and neuroendocrine function. It is not an approved pharmaceutical in the United States or the European Union.